Warfarin dose requirement and CYP2C9 polymorphisms
- PMID: 10371596
- DOI: 10.1016/S0140-6736(05)77184-1
Warfarin dose requirement and CYP2C9 polymorphisms
Comment on
-
Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications.Lancet. 1999 Feb 27;353(9154):717-9. doi: 10.1016/S0140-6736(98)04474-2. Lancet. 1999. PMID: 10073515
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical